Pharmaceutical care reducing the impact of the COVID-19 pandemic on the cardiovascular health of hypertensive and diabetic patients
DOI:
https://doi.org/10.11606/issn.2176-7262.rmrp.2023.209939Keywords:
Hypertension, Diabetes mellitus, Pharmaceutical services, COVID-19Abstract
Introduction: The COVID-19 pandemic has impacted the provision of health services to patients with chronic diseases, and the Medication Therapy Management, an integral part of pharmaceutical care can lead to an improvement in clinical parameters impacted by the pandemic. The objective of this study was to assess the clinical impact of
MTM-PC on systemic arterial hypertension and diabetes mellitus (DM) in comparison with the changes imposed by the COVID-19 pandemic in the primary healthcare scope. Methods: This is a quasi-experimental, single-arm, before-and-after study, with data collection from July 1, 2019 to October 31, 2022. Data from patients at the pharmaceutical
services, of the teaching-Pharmacy of UFJF, were included in the study and were divided into pre-pandemic and pandemic period, considering baseline data and the data related to the reintroduction of face-to-face care in the office as an endpoint.. Data were collected on blood pressure, lipidic profile, glycemia, use of statins and acetylsalicylic acid, cardiovascular risk, and psychosocial data, consequences of social isolation on mental health, medication prescription and life habits. Data were analyzed using the MINITAB v19 software, considering a significance level of 5%. Results: During the pandemic without MTM-PC it was found that blood pressure and HDL increased comparing the pre-pandemic with the pandemic without MTM-PC, respectively, SBP 117.5±8.86 and 134.75±12.43; DBP 71.25±3.54 and 83.25±11.65; HDL 45.25±7.80 and 52.38±12.52. Comparatively, it was verified that the blood pressure values were maintained and, the MTM-PC changed parameters like HbA1c 7.890±1.798, [p=0.028] and 7.325±1.30; HDL48.00±6.00 and 59.00±10.56, [p=0.020]. There was a change in both mean of cardiovascular risk, the global scale 13.69±8.08 to 22.38±7.28 and the optimized scale 8.35±6.71 to 16.10±5.83, [p=0.38], with a break in the trend of increased risk with the MTM-PC. The therapeutic load of drugs used for hypertension and diabetes remained below the limit value of 75%. Conclusion: There was evidence that the pandemic changed parameters such as blood pressure and cardiovascular risk. Additionally, the MTM-PC may be able to reduce the impact of the pandemic on glycated hemoglobin, improve HDL cholesterol levels and break a trend of increased cardiovascular risk.
Downloads
References
OPAS. OMS revela principais causas de morte e incapacidade em todo o mundo entre 2000 e 2019. [Internet]; 2020. Available from: https://www.paho.org/pt/noticias/9-12-2020-oms-revela-principais-causas-morte-e-incapacidade-em-todo-mundo-entre-2000-e
Ministério da Saúde. Vigitel Brazil 2020: surveillance of risk and protective factors for chronic diseases by telephone survey: estimates of frequency and sociodemographic distribution of risk and protective factors for chronic diseases in the capitals of the 26 Brazilian states and the Federal District in 2020. [Internet]; 2021 acess in 12 august 2022. Available from: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/vigitel/relatorio-vigitel-2020-original.pdf
MINISTÉRIO DA SAÚDE SECRETARIA DE CIÊNCIA, TECNOLOGIA, INOVAÇÃO E INSUMOS ESTRATÉGICOS PORTARIA SCTIE/MS No 54, DE 11 DE NOVEMBRO DE 2020 [Internet]. Available from: http://conitec.gov.br/.
Barroso WKS, Rodrigues CIS, Bortolotto LA, Mota-Gomes MA, Brandão AA, de Magalhães Feitosa AD, et al. Brazilian guidelines of hypertension - 2020. Arq Bras Cardiol. 2021;116(3):516–658.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine. 2020 Feb 20;382(8):727–33.
World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 52. [Internet]; 2020 access in august 12 2022. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200312-sitrep-52-covid-19.pdf?sfvrsn=e2bfc9c0_4
Malta DC, Gomes CS, da Silva AG, Cardoso LS de M, Barros MB de A, Lima MG, et al. Use of health services and adherence to social distancing by adults with noncommunicable diseases during the COVID-19 pandemic, Brazil, 2020. Ciencia e Saude Coletiva. 2021;26(7):2833–42.
Payne R, Slight S, Franklin BD, Avery AJ. World Health Organization. Department of Service Delivery and Safety. Medication errors. 28 p.
Canevini MP, De Sarro G, Galimberti CA, Gatti G, Licchetta L, Malerba A, et al. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia. 2010 May 1;51(5):797–804.
Souza Cazarim M, Da Silva De Oliveira L, Kobayashi JM, Apunike AC, Pereira LRL, Alves D. Pharmequi: A tool to improve the clinical practice regarding pharmacotherapy and drug utilization. In: Procedia Computer Science. Elsevier B.V.; 2018. p. 20–6.
Bukhari, N., Rasheed, H., Nayyer, B., & Babar, Z. U. D. (2020). Pharmacists at the frontline beating the COVID-19 pandemic. Journal of pharmaceutical policy and practice, 13(1), 1-4.
Visacri MB, Figueiredo IV, Lima T de M. Role of pharmacist during the COVID-19 pandemic: A scoping review. Vol. 17, Research in Social and Administrative Pharmacy. Elsevier Inc.; 2021. p. 1799–806.
Cazarim, M. D. S., De Freitas, O., Penaforte, T. R., Achcar, A., & Pereira, L. R. L. (2016). Impact assessment of pharmaceutical care in the management of hypertension and coronary risk factors after discharge. PloS one, 11(6), e0155204.
Gonçalves, A. C. O., de Souza Cazarim, M., Sanches, C., Pereira, L. R. L., Camargos, A. M. T., Aquino, J. A., & Baldoni, A. O. (2019). Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitus. BMJ Open Diabetes Research and Care, 7(1), e000647.
Gonçalves, A. C.O., Cazarim, M. S., Sanches, C., Pereira, L. R. L., Camargos, A. M. T., de Azevedo Aquino, J., ... & Baldoni, A. O. (2022). Avaliação econômica de uma estratégia individual de empoderamento farmacoterapêutico: um modelo em longo prazo aplicado do diabetes mellitus tipo II. Journal of Health & Biological Sciences, 10(1), 1-12.
Ghibu, S., Juncan, A. M., Rus, L. L., Frum, A., Dobrea, C. M., Chiş, A. A., ... & Morgovan, C. (2021). The particularities of pharmaceutical care in improving public health service during the COVID-19 pandemic. International Journal of Environmental Research and Public Health, 18(18), 9776.
Koster, E. S., Philbert, D., & Bouvy, M. L. (2021). Impact of the COVID-19 epidemic on the provision of pharmaceutical care in community pharmacies. Research in Social and Administrative Pharmacy, 17(1), 2002-2004.
Faculdade de Farmácia. Farmácia Universitária: serviços.[Internet]; Access in August 15 2022. Available from: https://www.ufjf.br/farmaciauniversitaria/servicos/
LLOYD-JONES, D. M. et al. Use of Risk Assessment Tools to Guide Decision- Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology. Journal of the American College of Cardiology, v. 73, n. 24, p. 3153– 3167, 25 jun. 2019.
Prefeitura de Juiz de Fora. Região de planejamento oeste. [Internet]; 2021 access in September 26 2022. Available from: https://www.pjf.mg.gov.br/desenvolvimentodoterritorio/dados/rp_oeste.php
Schmidt B, Crepaldi MA, Bolze SDA, Neiva-Silva L, Demenech LM. Mental health and psychological interventions during the new coronavirus pandemic (COVID-19). Estudos de Psicologia (Campinas). 2020;37.
Ornell F, Schuch JB, Sordi AO, Kessler FHP. Pandemia de medo e Covid-19: impacto na saúde mental e possíveis estratégias. Debates em Psiquiatria. 2020 Jun 30;10(2):12–6.
Manfrinato C V., Marino A, Condé VF, Franco MDCP, Stedefeldt E, Tomita LY. High prevalence of food insecurity, the adverse impact of COVID-19 in Brazilian favela. Public Health Nutr. 2021 Apr 1;24(6):1210–5.
Malta DC, Gomes CS, Barros MB de A, Lima MG, de Almeida W da S, de Sá ACMGN, et al. Noncommunicable diseases and changes in lifestyles during the covid-19 pandemic in brazil. Revista Brasileira de Epidemiologia. 2021;24.
Souza TCM, Oliveira LA, Daniel MM, Ferreira LG, Della Lucia CM, Liboredo JC, et al. Lifestyle and eating habits before and during COVID-19 quarantine in Brazil. Public Health Nutr. 2022 Jan 10;25(1):65–75.
Brito LMS, de Lima VA, Mascarenhas LP, Mota J, Leite N. Physical activity, eating habits and sleep during social isolation: From young adult to elderly. Revista Brasileira de Medicina do Esporte. 2021 Jan 1;27(1):21–5.
Penha IN da S, Santos ALM, Marinho ACH de F, Alves LA. O uso de medicamentos controlados durante a pandemia da Covid-19 observado em uma drogaria na região do sudoeste baiano. Research, Society and Development. 2021 Dec 12;10(16):e246101623752.
Lopes JM, Nascimento FBR do, Braga AO, Silva Junior AV de B, Araujo SV de L, Leite YK de C. Uso elevado de psicofármacos durante a pandemia da COVID-19: uma análise a partir de levantamentos epidemiológicos. Research, Society and Development. 2022 Jun 26;11(8):e47511831180.
Subramani, T., Kunchithapatham, S., & Ismail, S. C. (2022). Evaluation of Health-related Quality of Life among Hypertensive Post-menopausal Women Using EQ-5D in India During COVID-19 Pandemic. Indian Journal of Pharmaceutical Education and Research, 56(4), 1232-1239.
Costa IBS da S, Zampa HB. The high pressure of fighting the covid-19 pandemic. Vol. 117, Arquivos Brasileiros de Cardiologia. Arquivos Brasileiros de Cardiologia; 2021. p. 922–3.
Feitosa FGAM, Feitosa ADM, Paiva AMG, Mota-Gomes MA, Barroso WS, Miranda RD, et al. Impact of the COVID-19 pandemic on blood pressure control: a nationwide home blood pressure monitoring study. Hypertension Research. 2022 Feb 1;45(2):364–8.
Borges, K. N. G., Oliveira, R C., Macedo, D A P, Santos, J do C., Pellizzer, L G M. O impacto da pandemia de COVID-19 em indivíduos com doenças crônicas e a sua correlação com o acesso a serviços de saúde. Rev Cient Esc Estadual Saúde Pública Goiás “Candido Santiago”. 2020;6(3), 1-15.
Reeves, L., Robinson, K., McClelland, T., Adedoyin, C. A., Broeseker, A., & Adunlin, G. (2021). Pharmacist interventions in the management of blood pressure control and adherence to antihypertensive medications: a systematic review of randomized controlled trials. Journal of Pharmacy practice, 34(3), 480-492.
S. R. Rodrigues, V. L. Esteves, T. D. Domingues, I. Duarte, D. M. Mendes, J. F. Impact of the COVID-19 Pandemic on the Metabolic Control of Type 2 Diabetes Mellitus in Primary and Secondary Health Care. Portuguese Journal of Diabetes.2022.17 (1): 4-14.
Tanji Y, Sawada S, Watanabe T, Mita T, Kobayashi Y, Murakami T, et al. Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown. Diabetes Res Clin Pract. 2021 Jun 1;176.
Biancalana E, Parolini F, Mengozzi A, Solini A. Short-term impact of COVID-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: a single-centre observational study. Acta Diabetol. 2021 Apr 1;58(4):431–6.
Karatas S, Yesim T, Beysel S. Impact of lockdown COVID-19 on metabolic control in type 2 diabetes mellitus and healthy people. Prim Care Diabetes. 2021 Jun 1;15(3):424–7.
Lee MS, Chen A, Zhou H, Herald J, Nayak R, Shen YJA. Control of Atherosclerotic Risk Factors During the COVID-19 Pandemic in the U.S. Am J Prev Med. 2023 Jan 1;64(1):125–8.
Pal R, Banerjee M, Yadav U, Bhattacharjee S. Statin use and clinical outcomes in patients with COVID-19: An updated systematic review and meta-analysis. Vol. 98, Postgraduate Medical Journal. BMJ Publishing Group; 2022. p. 354–9.
Silva J. D. Análise das variações dos preços e do consumo dos medicamentos da Atenção Primária em Saúde do município de Porto Alegre no curso da pandemia da Covid-19. Porto Alegre: Universidade Federal do Rio Grande do Sul, 2021. Trabalho de Conclusão de Curso.
Liu, S., Luo, P., Tang, M., Hu, Q., Polidoro, J. P., Sun, S., & Gong, Z. (2020). Providing pharmacy services during the coronavirus pandemic. International journal of clinical pharmacy, 42, 299-304.
Haji Aghajani M, Moradi O, Amini H, Azhdari Tehrani H, Pourheidar E, Rabiei MM, et al. Decreased in-hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID-19. J Med Virol. 2021 Sep 1;93(9):5390–5.
Frazer JS, Frazer GR. Analysis of primary care prescription trends in England during the COVID-19 pandemic compared against a predictive model. Fam Med Community Health. 2021 Aug 3;9(3).
M. W. Lammers, Y. A. Hekster, A. Keyser, H. Meinardi, W. 0. Renier, H. van Lier. Monotherapy or Polytherapy for Epilepsy Revisited: A Quantitative Assessment. Epilepsia. 1995. 36(5); 440-446.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Nathália Castilho Roque, Vitor Franco Machado, Maurilio Souza Cazarim
This work is licensed under a Creative Commons Attribution 4.0 International License.
